pemafibrate
kowa pharmaceuticals
['valent ,(-prevalent)']
 we're working from two very different paradigms. i posit hdl-c and tg downstream of metabolic functionality will not be equivalent to rx interventions for same outcome. this is why we need to study lmhrs.
Engineering / Lipidology / Citizen+Formal Science
?? https://t.co/tKrrIdG1Yf (501c3)
?? https://t.co/EhKewtOfxz
?? https://t.co/D1LrI2dtIi